CONDENSED CONSOLIDATED INTERIM STATEMENT OF LOSS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
EXPENSES
Accretion expense	$ 28,017	$ 28,018	$ 85,943	$ 85,944
Consulting	128,605	131,488	399,351	323,788
Directors' fees	20,000	20,000	60,000	60,000
Filing and regulatory	10,629	7,166	26,785	34,859
Foreign exchange (gain) loss	7,331	(15,896)	39,669	(25,782)
General and administrative	48,198	46,698	262,822	290,577
Geological, mineral, and prospect costs	79,132	215,787	337,691	596,121
Interest expense	71,704	29,524	194,952	88,226
Professional fees	221,727	83,472	458,551	384,414
Promotion and shareholder communication	91,190	22,416	149,597	91,276
Share-based compensation	406,790	0	406,790	560,792
Salaries	33,750	30,465	101,250	103,422
Loss	(1,147,073)	(599,138)	(2,523,401)	(2,593,637)
Gain on fair value adjustment on derivative liability	187,652	277,805	252,324	1,560,945
Other income	(20)	473	14,887	4,280
Net loss and comprehensive loss for the period	$ (959,441)	$ (320,860)	$ (2,256,190)	$ (1,028,412)
Basic and diluted loss per common share	$ (0.03)	$ (0.01)	$ (0.08)	$ (0.04)
Weighted average number of common shares outstanding (basic and diluted)	32,787,798	26,770,298	28,798,174	26,578,269